Stroke Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- People aged 21 or older, of any race or gender
- People who have had their first-ever stroke (either a blocked blood vessel or a bleed in the brain), confirmed by a brain scan, and where the stroke happened at least 3 months ago
- People who have weakness in one arm as measured by a standard arm movement assessment (confirm with trial site for exact score details)
- People whose affected hand muscles show a measurable response to a type of non-invasive brain stimulation used in the study (confirm with trial site)
Who may not be able to join:
- People who have had strokes affecting both sides of the brain
- People who have another nerve or muscle condition (aside from the stroke) that affects movement in their arms
- People with a history of depression or other mental health conditions that are not well controlled by medication, either before or after the stroke, and that may affect their ability to take part
- People with very high blood pressure that is not controlled by medication at the time of joining the trial (specific blood pressure levels apply — confirm with trial site)
- People with certain metal implants or devices in their body, such as a pacemaker or metal fragments, including near the eyes
- People with a history of seizures either before or after their stroke
- People with existing scalp wounds, skull defects, or who have had part of their skull removed
- People currently taking part in another clinical trial focused on stroke recovery
- People where there are concerns about their ability to follow the study procedures and attend appointments
- People who are pregnant
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Principal Investigator: Wayne Feng, MD, Duke University
Phone: 919 681 1700
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
To determine whether there is overall stimulation effect among three stimulation paradigms (FiTBS600; FiTBS2400; DiTBS2400) on the ipsilesional corticospinal excitability of a hand muscle.
Can't join this trial?
Data last synced from ClinicalTrials.gov: 22 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.